Medtecs International Corporation Ltd DRC (9103) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medtecs International Corporation Ltd DRC (9103) has a cash flow conversion efficiency ratio of 0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$2.80 Million ≈ $88.32K USD) by net assets (NT$102.11 Million ≈ $3.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medtecs International Corporation Ltd DR market cap and net worth for the company's overall valuation and market capitalisation.
Medtecs International Corporation Ltd DRC - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Medtecs International Corporation Ltd DRC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medtecs International Corporation Ltd DRC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medtecs International Corporation Ltd DRC ranked by their cash flow conversion efficiency. Explore earnings quality score of Medtecs International Corporation Ltd DR to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TC Bancshares Inc
NASDAQ:TCBC
|
0.018x |
|
Kumkang Kind
KO:014280
|
-0.020x |
|
ASolid Technology Co Ltd
TWO:6485
|
0.027x |
|
Enterprise Group Inc
TO:E
|
0.006x |
|
Maywood Acquisition Corp. Unit
NASDAQ:MAYAU
|
-0.002x |
|
New Delhi Television Limited
NSE:NDTV
|
1.199x |
|
Max India Limited
NSE:MAXIND
|
-0.112x |
|
Rich Honour International Designs Co Ltd
TW:6754
|
0.114x |
Annual Cash Flow Conversion Efficiency for Medtecs International Corporation Ltd DRC (2009–2025)
The table below shows the annual cash flow conversion efficiency of Medtecs International Corporation Ltd DRC from 2009 to 2025. View latest Medtecs International Corporation Ltd DR stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$102.11 Million ≈ $3.22 Million |
NT$-1.88 Million ≈ $-59.09K |
-0.018x | -730.28% |
| 2024-12-31 | NT$107.05 Million ≈ $3.37 Million |
NT$312.00K ≈ $9.83K |
0.003x | +105.29% |
| 2023-12-31 | NT$130.31 Million ≈ $4.11 Million |
NT$-7.18 Million ≈ $-226.37K |
-0.055x | -107.22% |
| 2022-12-31 | NT$152.31 Million ≈ $4.80 Million |
NT$-4.05 Million ≈ $-127.69K |
-0.027x | -116.61% |
| 2021-12-31 | NT$187.91 Million ≈ $5.92 Million |
NT$30.10 Million ≈ $948.44K |
0.160x | -69.33% |
| 2020-12-31 | NT$194.49 Million ≈ $6.13 Million |
NT$101.59 Million ≈ $3.20 Million |
0.522x | +672.04% |
| 2019-12-31 | NT$64.59 Million ≈ $2.03 Million |
NT$4.37 Million ≈ $137.68K |
0.068x | -23.80% |
| 2018-12-31 | NT$63.35 Million ≈ $2.00 Million |
NT$5.62 Million ≈ $177.22K |
0.089x | +136.05% |
| 2017-12-31 | NT$62.92 Million ≈ $1.98 Million |
NT$2.37 Million ≈ $74.57K |
0.038x | -50.48% |
| 2016-12-31 | NT$61.86 Million ≈ $1.95 Million |
NT$4.70 Million ≈ $148.04K |
0.076x | -33.63% |
| 2015-12-31 | NT$60.46 Million ≈ $1.90 Million |
NT$6.92 Million ≈ $218.02K |
0.114x | -27.82% |
| 2014-12-31 | NT$56.24 Million ≈ $1.77 Million |
NT$8.92 Million ≈ $280.97K |
0.159x | +72.61% |
| 2013-12-31 | NT$56.53 Million ≈ $1.78 Million |
NT$5.19 Million ≈ $163.61K |
0.092x | +58.69% |
| 2012-12-31 | NT$56.56 Million ≈ $1.78 Million |
NT$3.27 Million ≈ $103.15K |
0.058x | -62.73% |
| 2011-12-31 | NT$54.60 Million ≈ $1.72 Million |
NT$8.48 Million ≈ $267.23K |
0.155x | +11.36% |
| 2010-12-31 | NT$53.45 Million ≈ $1.68 Million |
NT$7.46 Million ≈ $234.90K |
0.139x | -40.33% |
| 2009-12-31 | NT$50.65 Million ≈ $1.60 Million |
NT$11.84 Million ≈ $373.06K |
0.234x | -- |
About Medtecs International Corporation Ltd DRC
Medtecs International Corporation Limited, an integrated healthcare services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups. It operates through Manufacturing, Hospital, and Distribution and Others segments. The Manufacturing segment produces and sub-contracts a range of medical consumables, including patients'… Read more